S U M M A R Y Human prostate cancer cells (DU145) implanted into nude mice are deficient in DNase activity. After administration of a vitamin C/vitamin K 3 combination, both alkaline DNase (DNase I) and acid DNase (DNase II) activities were detected in cryosections with a histochemical lead nitrate technique. Alkaline DNase activity appeared 1 hr after vitamin administration, decreased slightly until 2 hr, and disappeared by 8 hr after treatment. Acid DNase activity appeared 2 hr after vitamin administration, reached its highest levels between 4 and 8 hr, and maintained its activity 24 hr after treatment. Methyl green staining indicated that DNase expression was accompanied by a decrease in DNA content of the tumor cells. Microscopic examination of 1-m sections of the tumors indicated that DNase reactivation and the subsequent degradation of DNA induced multiple forms of tumor cell death, including apoptosis and necrosis. The primary form of vitamin-induced tumor cell death was autoschizis, which is characterized by membrane damage and the progressive loss of cytoplasm through a series of self-excisions. These self-excisions typically continue until the perikaryon consists of an apparently intact nucleus surrounded by a thin rim of cytoplasm that contains damaged organelles.
P rostate carcinoma is one of the most prevalent malignant tumors of the male reproductive organs, with an estimated 179,300 cases and 37,000 deaths reported annually (Moon 1992; Greenlee et al. 2000) . The prostate is an androgen-dependent tubulo-alveolar glandular organ whose epithelial cells possess androgen receptors and depend on a constant supply of testosterone for their survival (Kyprianou and Isaacs 1988) . Androgen ablation has been the first-line treatment for patients with androgen-dependent prostate carcinoma because it induces the cessation of cell proliferation and the activation of programmed cell death (apoptosis) via activation of a Ca 2 ϩ , Mg 2 ϩ -dependent endonuclease which is identical or closely related to deoxyribonuclease I (DNase I) (Mahler and Denis 1992; Vogelzang and Kennealy 1992; Peitsch et al. 1993; Rausch et al. 1997) . In advanced carcinoma, 70-80% of men initially respond well to androgen withdrawal, but almost all patients relapse because of the development of hormone-resistant and hormoneindependent cells (Berchem et al. 1995) . Chemotherapy (the second-line treatment) has not been effective against hormone-independent prostate cancer. The lack of response of hormone-independent prostate cancer cells to a wide range of cytotoxic drugs demonstrates the need for development of more effective treatment modalities, especially those that can reactivate latent DNases.
The results of previous studies demonstrate that the activity of alkaline DNase (DNase I; EC 3.1.21.1) and acid DNases (DNase II; EC 3.1.22.1) is inhibited in non-necrotic cells of malignant tumors in men and in experimental animals, as well as during the early stages of experimental carcinogenesis (Taper 1967; Taper and Bannasch 1976; Fort et al. 1974; Taper et al. 1971a,b) . Because alkaline and acid DNase reactivation occurred in spontaneous and induced tumor necroses and regression (Taper 1980; Taper et al. 1981) , compounds capable of reactivating DNase in tumor cells should offer a great potential for therapeutic intervention in cancer. It has been found that vitamin K 3 (2-methyl-1-4-naphthoquinone) selectively reactivated alkaline DNase in malignant tumor cells, whereas vitamin C (ascorbic acid, or sodium ascorbate) exclusively reactivated acid DNase (Taper 1980) . A combined administration of vitamin C and vitamin K 3 (at a single IP dose of vitamin C ϭ 1 g/kg body weight and vitamin K 3 ϭ 0.01 g/kg) in ascites tumor-bearing mice synergistically increased the lifespan of the mice by 45%. Separate administration of vitamin C increased lifespan by 14.7% and vitamin K 3 alone by 1.07% (Taper et al. 1987) . Combined vitamin C and K 3 treatment also potentiated the effects of chemotherapy induced by six different cytotoxic drugs (Taper et al. 1987) , sensitized a mouse tumor that was resistant to vincristine (Taper and Roberfroid 1992) , and potentiated the therapeutic effects of radiotherapy (Taper et al. 1996) .
The tumor growth-inhibiting and -chemosensitizing effects of the vitamin C and K 3 combination were confirmed by in vitro experiments with different lines of human tumor cells (Noto et al. 1989; De Loecker et al. 1993) . These in vitro studies were extended to a battery of human urological tumor cell lines, including DU145, an androgen-independent prostate carcinoma cell line (Gilloteaux et al. 1995; Jamison et al. 1997; Venugopal et al. 1996a,b; Jamison et al. in press) . In this study, we have investigated the therapeutic affect of the vitamin C and K 3 combination on human prostate carcinoma cells (DU145) that had been transplanted into 5-week-old male NCr athymic nude mice.
Materials and Methods

Tumor Cells
The human androgen-independent prostate carcinoma DU145 cell line was obtained from the American Type Culture Collection (Rockville, MD) and was grown in McCoy's 5A medium (M5A; Gibco, Grand Island, NY). All media were supplemented with 10% fetal bovine serum (FBS; Gibco), 2.2 g/ liter NaHCO 3 (Gibco), and 50 g/ml gentamicin sulfate (Fisher Scientific; Pittsburgh, PA). Cells were grown as adherent cells in a humidified atmosphere at 37C in 5% CO 2 . When the tumor cells were used for experiments, they were harvested with trypsin-ethylenediamine tetraacetic acid (EDTA) (JRH Biosciences; Lenexa, KS), washed with PBS, pH 7.4, and resuspended in M5A. Cells were counted with a hemocytometer using trypan blue (Gibco) exclusion to determine the number of viable cells.
Reagents
Vitamin C (VC) and menadione bisulfite (VK 3 ) were purchased from Sigma Chemical (St Louis, MO) and were dissolved in PBS to create oral vitamin doses of VC ϭ 15 g/liter and VK 3 ϭ 0.15 g/liter. The IP doses of the vitamins were VC ϭ 1 g/kg body mass and VK 3 ϭ 10 mg/kg body mass as optimized and described by Taper and co-workers (1987) . All vitamins were prepared in a darkened laminar flow hood to prevent photo-inactivation.
Animals
Male athymic nude mice (NCr-nu/nu; 4 weeks old) were purchased from Taconic Farms (Germantown, NY) and maintained in microinsulator cages (within the AALACaccredited NEOUCOM Comparative Medicine Unit) in a pathogen-free isolation facility. After a 1-week isolation period, 1 ϫ 10 6 DU145 cells in a 100-l volume of M5A medium were injected SC into the median and dorsal scapular region. After 4 weeks, the mice were weighed and divided into six groups of four animals each. Five of the six groups were given 100 l of the VC/VK 3 combination by gavage and then immediately given an additional 100-l dose of the vitamin combination by IP injection. Control mice received two 100-l doses of PBS. The mice were sacrificed by carbon dioxide inhalation at 1, 2, 4, 8, or 24 hr after vitamin administration. The tumors were then surgically removed and trisected. One third of the tumor was flash-frozen in liquid nitrogen and stored at Ϫ 80C. The second third of the tumor was fixed in Carnoy's fixative for 3 hr, processed, and embedded in paraffin. The final third of the tumor was fixed in buffered glutaraldehyde and processed in epoxy resin for future electron microscopic observations as described below.
All animal procedures were performed under protocols approved by the Northeastern Ohio Universities College of Medicine Animal Care and Use Committee.
Plastic Sections
One third of each tumor from vitamin-treated and shamtreated mice was fixed in buffered glutaraldehyde solution (3.2% in 0.1 M phosphate buffer, pH 7.32) and processed for ultrastructural observations in epoxy resin (Polysciences, PolyBed 812; Warrington, PA) (Gilloteaux et al. 1995) . One-m-thick sections were cut and stained with Toluidine blue. Several of these specimens were examined, and selected micrographs were used in this presentation. Photomicrographs were taken with a Leitz and an Olympus AX 70 Provis photomicroscope. The numbers of mitotic, apoptotic, and necrotic cells were quantified by scoring 500 tumor cells per field in five random fields per tissue section. Statistical analysis was done by means of an unpaired Student's t -test to compare control and test sections.
Histochemical Detection of DNase Activity
The histochemical activity of alkaline and acid DNases was detected in cryosections of the frozen tumor specimens using a modified Gomori's lead nitrate method (Vorbrodt 1961; Taper 1968 ). Fresh cryostat tissue sections were fixed for 15 min in 10% formol-calcium, briefly washed in distilled water, and incubated for 3 hr at 37C in a medium that con-tained lead nitrate and DNA. For acid DNase activity, the reaction buffer contained 0.2 M acetate buffer, pH 5.9, and acid phosphatase. For alkaline DNase activity, the reaction buffer contained 0.2 M Tris-maleate, pH 8.0, magnesium chloride, and alkaline phosphatase. After incubation, the sections were washed for 5 min in distilled water, stained in dilute ammonium sulfide solution, washed again in distilled water, and mounted with aquamount. The sites of enzymatic activity were revealed by deposits of black lead sulfide. Control sections incubated in medium without substrate were included and exhibited no histochemical staining.
Histochemical Detection of Nucleic Acids
Nucleic acid staining was performed using the classic methyl green-pyronin technique of Brachet (1946) as modified by Godlewski and Vorbrodt (1954) . The embedded tumors were cut into 5-m sections, dewaxed in two xylene treatments, and brought to distilled water through ethanol changes (100%, 75%, 50%). The sections were stained for 2 hr with methyl green-pyronin Y in 0.1 M acetate buffer, pH 4.7, washed rapidly with water, and then dried with filter paper. The sections were dehydrated in 95% ethanol:100% isopropyl alcohol (1:7) and then in 100% isopropyl alcohol. The sections were then cleared in xylene and mounted with aquamount. Methyl green staining intensity of five fields of 100 control cells and five fields of 100 vitamin-treated cells was measured with an image analyzer and recorded in terms of optical density (Schulte et al. 1992) . Statistical analysis was done by an unpaired Student's t -test to compare control and test sections. Figure 1 summarize the results of the histochemical determination of alkaline and acid DNase activity in the tumors at different time intervals after single-dose administration of IP and oral vitamins C and K 3 or PBS administration. As shown in Table 1 , the sham-treated tumors exhibited little if any alkaline and acid DNase activity. However, after combined vitamin C and K 3 treatment, alkaline DNase activity appeared sooner than the acid DNase activity. This positive alkaline DNase activity was significant, appeared as early as 1 hr after vitamin administration, and decreased slightly until 2 hr after vitamin treatment. Alkaline DNase activity gradually diminished until 8 hr after vitamin administration and then disappeared. Acid DNase activity appeared 2 hr after vitamin administration, reached its highest level 4-8 hr after treatment, and maintained its activity 24 hr after treatment. Figure 1 is a montage of representative light micrographs of tumor sections that were stained for alkaline or acid DNase activities. One hour after combined vitamin C and K 3 injection, alkaline DNase demonstrated distinct activity in the cytoplasm. However, the majority of alkaline DNase activity was found in the nuclei of tumor cells (Figure 1, 1h ). As described in Table 1 , alkaline DNase activity gradually decreased and was not evident after 4 hr. Very low to undetectable alkaline DNase activity was seen in the sham tumor cells (Figure 1 , C). Conversely, little acid DNase activity was observed until 4 hr after vitamin treatment. At this time, intense acid DNase activity was detected primarily in the nuclei of the tumor cells ( Figure  1, 4h ). Acid DNase activity gradually decreased. Substantial activity was still evident 24 hr after vitamin treatment. Sham-treated tumor cells exhibited little acid DNase activity (Figure 1, C) .
Results
Table 1 and
The consequence of the reactivation of alkaline and acid DNases could be seen in tumor cells 24 hr after vitamin C and K 3 treatment. When the nucleic acids of sham-treated tumor cells were stained with methyl green-pyronin Y, intense methyl green staining was visible in the nucleus and intense pyronin Y staining was observed in the cytoplasm (Figure 2A ). In vitamin-treated tumor cells ( Figure 2B ), the methyl green staining was greatly diminished, indicative of a decrease in DNA content. Densitometric analysis of the staining intensity of control and vitamin-treated tumor cells produced optical density values of 0.63 Ϯ 0.11 and 0.37 Ϯ 0.07, respectively. These values indicate a statistically significant ( p Ͻ 0.01) decrease in DNA staining. Pyronin Y staining diminished at a more rapid rate and to an even greater extent than the methyl green staining, indicative of decreased RNA content. This suggests that this combined vitamin treatment may also reduce transcription or induce the activation of RNases. Figure 3 is a set of micrographs of hematoxylinand eosin-stained sections of sham-treated and vitamin-treated tumors 4 hr after treatment. The cells in the sham-treated tumor ( Figure 3A ) exhibited pleomorphic cellular and nuclear morphology. The presence of mitotic figures indicated that cells in this tumor were still actively dividing. Sections of the control tumor exhibited an average of 5 Ϯ 1 mitotic figures/ 500 cells. Conversely, the cells in the vitamin-treated section ( Figure 3B ) averaged 1.23 Ϯ 0.84 mitotic fig- ures/500 cells. Although the incidence of mitosis was small, the difference between control and vitamintreated cells was statistically significant ( p Ͻ 0.01). The nuclei of some cells appeared pyknotic, whereas other cells contained nuclei with marginated chromatin and predominant condensed nucleoli. This section was also characterized by the presence of many vacuolated cells and the presence of necroses. Figures 4-6 is a gallery of light micrographs of Toluidine blue-stained sections of vitamin-treated tumors 4 hr after treatment, depicting tumor cells in various stages of cell injury and cell death. These micrographs are characteristic of this tumor and reveal a plain, compact mass with few capillaries and little to no mitotic activity. The poor vascularization of these tumors (v ϭ 250 mm 3 ) is probably not a function of vitamin treatment because angiogenesis in tumors derived from DU145 cells is greatly diminished compared to that of other prostate cancer cell lines (Connolly and Rose 1998). However, the cells comprising the tumor exhibited cellular and nuclear pleiomorphism. Nuclear pleomorphism was especially evident in the broad range of nuclear size. In Figure 4 , the peripheral cytoplasm of the large tumor cell, with the enormous nucleus, displayed a great deal of damage in the form of fine plasmalemmal vacuolizations and su- perficial exoplasmic vacuoles. The membrane defects associated with these vacuolizations suggest that this large cell was in the process of excising a large autoschizic body which is delineated by a peripheral line of vacuoles (curved open arrow). In addition, this large cell contained a large phagosome (curved dark arrow) digesting an apoptotic (nuclear) body that was the remnant of an adjacent apoptosis. The neighboring cells also possessed a small number of vacuoles and phagosomes. Many of these cells showed nuclei with condensed eccentric to centrally located nucleoli and marginated chromatin.
Figures 5 and 6 display similar but more exacerbated cell changes that result in multiple types of cell death, including necrosis, apoptosis, and autoschizis. Whereas necrosis, apoptosis, and autoschizis were not observed in control tumor cells, an average of 9.0 Ϯ 2.1 autoschizic, 3.0 Ϯ 1.1 necrotic, and 1.97 Ϯ 0.45 apoptotic cells were observed per 500 cells after vitamin treatment. These results are consistent with the results obtained with annexin V-propidium iodidelabeled cells (Ervin et al. 1999 ). In the lower righthand corner of Figure 5 , the pale staining cells with the round to ovoid euchromatic nuclei are intact tumor cells that have not yet been affected by vitamin treatment. The cells shown in the inset are from a field of view adjacent to that shown in Figure 5 . These cells are undergoing apoptosis and show crescentic condensation of chromatin, cell rounding and greatly reduced amounts of cytoplasm that are characteristic of this type of cell death. The majority of the remaining cells that display hyperchromaticity and intense vacuoliza- tion are in the process of cell necrosis through autoschizis.
The process of autoschizis is more evident in Figure  6 , in which the vacuolizations are marked by stars and the cytoplasmic excisions are labeled with arrowheads, with intercellular vacuolizations and exaggerated intercellular spaces (i). These autoschizic tumor cells were found lining the necrotic foci of the tumor, which often form around capillaries such as the one in the center of Figure 6 . These cells are characterized by exaggerated membrane damage and by a process of progressive loss of cytoplasm in which the perikaryal compartment separates from the main cytoplasmic cell body in a series of self-excisions. These self-excisions (dark arrowheads with short shafts) typically continue until the perikaryon consists of an apparently intact nucleus and a thin rim of cytoplasm containing damaged organelles. The excised cytoplasmic blebs are primarily filled with dense glycogen patches but contain no organelles or nuclear fragments. These cells are characterized by exaggerated membrane damage and by progressive loss of cytoplasm in which the perikaryal compartment separates from the main cytoplasmic cell body in a series of self-excisions. During autoschizis, nucleoplasm becomes more chromatic and nuclear size decreases. Therefore, the size of the resultant autoschizic cell or body is much smaller than the tumor cell from which it originated.
Discussion
Because endonuclease activation is one of the earliest changes denoting irreversible commitment to cell death, it is generally believed to be involved in the triggering of cell death rather than to be the result of it. Several candidate deoxyribonuclease molecules have been identified in various cell lines and tissues, including the caspase-activated DNA fragmentation factor caspase-3-activated DNase (DFF40/CAD) nuclease, DNase I, and DNase II. DFF endonuclease is primarily responsible for mediating DNA laddering during apoptosis after its activation by caspases (mainly caspase 3). DFF is composed of two subunits, a 40-kD caspase-3-activated nuclease and its 45-kD inhibitor. This protein complex resides in the nucleus and is activated by caspase-3 cleavage of the inhibitor and its subsequent dissociation from the endonuclease. The activated endonuclease exhibits a pH optimum of 7.5, requires Mg 2 ϩ (not Ca 2 ϩ ), and is inhibited by Zn 2 ϩ (Inohara et al. 1999; Widlak et al. 2000) . Although the pH optimum, nuclear localization, and other factors suggest that the DFF40/CAD nuclease may be the reactivated alkaline DNase, a number of other factors argue that another DNase is primarily responsible for the DNase cleavage observed during vitamin-induced tumor cell death. First, autoschizis rather than apoptosis is the predominant form of vitamin-induced tumor cell death, and the DFF40/CAD nuclease is associated with apoptotic cell death. Second, preliminary studies conducted in our laboratories indicate that caspase-3 activation by the vitamin combination is marginal and only occurs 3 to 4 hr after vitamin treatment (data not shown). Third, electrophoretic gels of DNA isolated from cell lines after vitamin treatment reveal a smearing pattern with a subdued laddering pattern embedded in it, which occurs as early as 1 hr after vitamin treatment (Ervin et al. 1999) . These results reveal a DNA degradation pattern that is inconsistent with DFF40/CAD nuclease activation and which precedes caspase-3 activation. Although these observations do not eliminate DFF40/CAD participation in later stages of the process, they do suggest that other DNases are involved.
Two of these DNases (DNase I and DNase II) are of particular interest because of their broad tissue distribution and because they have been implicated as possible effectors of apoptosis (Peitsch et al. 1994; Krieser and Eastman 1998) . DNase I has an alkaline pH optimum around 7.5, with enzymatic activity occurring in a pH range of 5.5-9.0. Although DNase I requires micromolar concentrations of both Ca 2ϩ and Mg 2ϩ for optimal enzymatic activity, the enzyme may be activated by 1 mM Mg 2ϩ alone. Subcellular fractionation studies have shown that DNase I is localized primarily in the mitochondria, with activity also being detected in the nucleus (Beaufay et al. 1959) . A more recent immunolocalization study indicates that substantial amounts of DNase I are also found in the endoplasmic reticulum/nuclear envelope (Peitsch et al. 1993) .
In contrast to DNase I, DNase II (acid DNase) does not require divalent cations for its activity (Allfrey and Mirsky 1952; Peitsch et al. 1994) . It has an acidic pH optimum at about 5.0, with enzymatic activity occurring in a pH range of 3.0-7.0. Subcellular fractionation studies demonstrate that although the specific activity of DNase II is highest in the lysosome, over 50% of the total cellular DNase II is located in the nuclear fraction. The presence of nuclear DNase II has also been confirmed in fixed tissue sections by histochemical detection with the lead nitrate method (Vorbrodt 1961) . Nuclear DNase II is very stable and is only slightly depleted after 24 hr, even in the presence of cycloheximide (Barry and Eastman 1993) .
The activity of alkaline and acid DNases is inhibited in non-necrotic cells of malignant tumors in humans and experimental animals (Taper 1967; Taper et al. 1971a,b; Fort et al. 1974; Taper and Bannasch 1976) . Reversal of this inhibition of DNase activity in malignant tumors has been linked to necrotic events and to efficient tumor therapy (Williams et al. 1974; Taper et al. 1981) . In a study employing transplant-able murine hepatoma cells, DNases have been shown to be reactivated in necrotic tumor cells after in vivo irradiation or in vitro treatment with a variety of different compounds.
The compounds that reactivate alkaline and acid DNase activities demonstrate a distinct enzymatic specificity (Festy and Paoletti 1963; Taper et al. 1981) . Sulfhydryl agents, including vitamin K 3 , exclusively reactivate alkaline DNase. Reducing agents, including vitamin C, reactivate acid DNase without any effect on alkaline DNase. The reactivation of alkaline DNase activity occurs rapidly (within 1 hr) and is of shorter duration than the reactivation of acid DNase. The reversal of acid DNase deficiency is delayed compared to that of alkaline DNase. However, once acid DNase activity is restored, its half-life is much longer than that of alkaline DNase (Taper et al. 1981) .
Although the relatively rapid reversiblity of the deficiency of alkaline DNase argues against a real decrease in enzyme content and the subsequent de novo synthesis of the DNase, the later time course of acid DNase activity could involve activation of both preexisting and de novo acid DNase synthesis (Taper et al. 1981) . At least in the case of the alkaline DNase, these observations point to a masking of enzymatic activity, either by structural latency (i.e., the release of sequestered DNases from other intracellular compartments) or by the presence of enzyme inhibitors (Sierakowska and Shugar 1977) . Furthermore, the lack of reactivation of DNases in tumor cells after treatment with phospholipases, as well as the inhibition of usually active DNases in normal rat liver by tumor homogenate, suggests that DNase deficiency in malignant cells is due to the presence of inhibitors and is not linked to structural latency (Taper et al. 1981) .
Protein nuclease inhibitors that bind to DNase molecules in a 1:1 ratio have been found in normal tissues (Lindbergh and Skoog 1970; Lesca 1976 ) and may even be increased in tumor cells (Loiselle and Carrier 1963) . In the case of DNase I, monomeric actin has been implicated as the inhibitory molecule (Lacks 1981; Peitsch et al. 1994) . A monomeric natural protein inhibitor of DNase II has been purified to homogeneity from bovine liver (Lesca 1976) . Small shifts in pH have been shown to affect the interaction between the inhibitor and DNase II and lead to recovery of nuclease activity (Lesca and Paoletti 1969) , whereas DNase I is reactivated by sulfhydryl reagents (Festy and Paoletti 1963) . However, the effects (if any) of vitamin C and vitamin K 3 on the DNase inhibitor complexes has not been eluicidated.
The results of the current study demonstrate that sham-treated tumor cells are essentially devoid of DNase activity. After administration of a vitamin C/Vitamin K 3 combination, both alkaline DNase (DNase I) and acid DNase (DNase II) activity was detected in cryo-sections of the frozen tumor specimens by a modified Gomori's lead nitrate method. Alkaline DNase activity appears as early as 1 hr after vitamin administration, decreases until 2 hr, and disappears by 8 hr after vitamin administration. Acid DNase activity appears 2 hr after vitamin administration, reaches its highest level 4-8 hr after treatment, and maintains its activity 24 hr after treatment. Methyl green staining indicates that DNase activity is accompanied by a decrease in DNA content of the tumor cells. Examination of 1-m sections of the vitamin-treated tumors indicates that vitamin-induced DNase reactivation and the subsequent degradation of DNA are sufficient to induce tumor cell death. Although both necrotic and apoptotic cell death are observed in the tumor, the primary form of vitamin-induced tumor cell death is autoschizis, a novel type of necrosis characterized by exaggerated membrane damage and the progressive loss of cytoplasm through a series of self-excisions. These self-excisions typically continue until the perikaryon consists of an apparently intact nucleus surrounded by a thin rim of cytoplasm containing damaged organelles (Gilloteaux et al. 1998 Ervin et al. 1999; Gilloteaux et al. in press) .
In vivo studies designed to determine the effect of vitamin administration on the lifespan of nude mice demonstrated that mice receiving both oral and IP vitamin lived significantly longer (pϽ0.01) than control mice. The results of additional in vivo studies, designed to determine the effect of vitamin administration on the growth of solid tumors in nude mice, demonstrated that administration of clinically attainable doses of oral vitamins ad libitum in drinking water could significantly reduce the growth rate of solid tumors in nude mice (pϽ0.05). Finally, nude mice receiving the vitamin combination did not exhibit any significant bone marrow toxicity, changes in organ weight, or pathological changes in these organs (Jamison et al. in press) . Additional experiments are in progress using transgenic mice that more closely mimic the development and metastases of prostate cancer in humans. Among the different mechanisms that may be involved in this therapeutic effect of combined vitamins against cancer, the most plausible is a stimulation of a redox cycling system that produces H 2 O 2 and other active oxygen species that are involved in cell membrane lipid peroxidation, DNase activation, and DNA breaks leading to cell death (Gilloteaux et al. 1995; Jamison et al. 1996 Jamison et al. ,1997 Venugopal et al. 1996a,b) . Moreover, the most important fact is that this action of combined vitamins C and K 3 appeared to be selective for cancer cells (Taper and Roberfroid 1992) . As opposed to normal organs and tissues, cancer cells are usually deficient in catalase, superoxide dismutase, and/or glutathione peroxidase, which constitute the cellular armamentarium system/defense system against free radicals (Sinha and Mimnaugh 1990) . This hy-pothesis is supported by the fact that simultaneous administration of vitamin C and K 3 with catalase suppressed the potentiating and sensitizing effect of these vitamins (Noto et al. 1989) . Because the vitamin combination is a chemosensitizer (Taper et al. 1987 ) and a radiosensitizer (Taper et al. 1996) , combined vitamin C and K 3 administration can be considered as a new, nontoxic adjuvant cancer therapy, which can be easily introduced into the classical protocols of clinical cancer therapy without any supplementary risk for patients. Taper HS (1968) 
